Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption (Q44070555)

29 November 2017

Pharmacological studies of diacerein in animal models of inflammation, arthritis and bone resorption (English)

1 reference

29 November 2017

0 references

1 reference

4

Kenji Ohmori

1 reference

29 November 2017

Tadafumi Tamura

1

1 reference

29 November 2017

Tomomi Shirai

series ordinal

2

1 reference

29 November 2017

Nobuo Kosaka

series ordinal

3

1 reference

29 November 2017

Nagatomo Takafumi

series ordinal

5

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

European Journal of Pharmacology

29 November 2017

1 reference

29 November 2017

448

1 reference

29 November 2017

81-87

1 reference

29 November 2017

1

1 reference

Prostaglandin E2 prevents bone loss and adds extra bone to immobilized distal femoral metaphysis in female rats

29 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Effects of diacerhein in an accelerated canine model of osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Effect of auranofin on plasma fibronectin, C reactive protein, and albumin levels in arthritic rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Influence of renal function on the pharmacokinetics of diacerein after a single oral dose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Fractal properties of subchondral cancellous bone in severe osteoarthritis of the hip.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Kinetics of the generation and action of chemical mediators in zymosan-induced inflammation of the rabbit peritoneal cavity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Inhibition of bone resorption in vitro by selective inhibitors of gelatinase and collagenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

A simple method to determine nanogram levels of 4-hydroxyproline in biological tissues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Interleukin-1 receptor antagonist decreases bone loss and bone resorption in ovariectomized rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Subchondral bone morphological and biochemical alterations in osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Composition and Mechanical Properties of Cancellous Bone from the Femoral Head of Patients with Osteoporosis or Osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Abnormal cancellous bone collagen metabolism in osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Comparative study of the effect of CV-6209, a specific PAF-antagonist, on rat paw edema caused by different phlogogen agents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Rhein: an anthraquinone that modulates superoxide anion production from human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Endogenous bone-resorbing factors in estrogen deficiency: cooperative effects of IL-1 and IL-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Effects of diacerhein on granuloma induced cartilage breakdown in the mouse.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Diacerhein in the treatment of osteoarthritis of the hip

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Clinical pharmacokinetics of diacerein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Protective effects of corticosteroids on cartilage lesions and osteophyte formation in the Pond-Nuki dog model of osteoarthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Efficacy and safety of diacerein in osteoarthritis of the knee: a double-blind, placebo-controlled trial. The Diacerein Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Mechanisms of cytokine induced bone resorption: role of nitric oxide, cyclic guanosine monophosphate, and prostaglandins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Interleukin-1 beta is a potent inhibitor of bone formation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Diacerein suppresses the increase in plasma nitric oxide in rat adjuvant-induced arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Rhein, an active metabolite of diacerein, down-regulates the production of pro-matrix metalloproteinases-1, -3, -9 and -13 and up-regulates the production of tissue inhibitor of metalloproteinase-1 in cultured rabbit articular chondrocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

Effects of diacerein on indomethacin-induced gastric ulceration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2802%2901898-8

10.1016/S0014-2999(02)01898-8

7 January 2021

Identifiers

DOI

1 reference

29 November 2017

1 reference